Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...
Inspired by kirigami, a type of Japanese paper art, researchers have created a new material that transforms from a grid into any 3D structure you'd like. Reading time 2 minutes There’s a very thin ...
Editor's Note: APYs listed in this article are up-to-date as of the time of publication. They may fluctuate (up or down) as the Fed rate changes. CNBC Select will update as changes are made public.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results